Rukoyatkina Natalia, Begonja Antonija J, Geiger Jörg, Eigenthaler Martin, Walter Ulrich, Gambaryan Stepan
Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany.
Br J Haematol. 2009 Feb;144(4):591-602. doi: 10.1111/j.1365-2141.2008.07506.x. Epub 2008 Nov 20.
Platelets stimulated by a combination of thrombin/convulxin have been shown to develop two to three populations characterized by different phosphatidylserine (PS) surface expression and integrin alpha IIb beta 3 activity. To determine how these markers are distributed on the surface of platelets/particles, we studied Annexin V and PAC-1 binding to platelets/particles of different sizes by flow cytometry analysis and evaluated influences of calpain and caspase inhibitors on thrombin/convulxin-activated platelets. Analysed platelets/particles were divided by their sizes, according to the standard size beads, into seven populations from 0.37 to 4.8 microm. PAC-1 binding/microm(2) was almost equal in platelets/particles ranging from 1.2 to 4.8 microm and was significantly lower on smaller-sized particles sizes (0.37-0.7 microm). PS surface exposure/microm(2) was high in the particles of 0.37-1.2 microm and very low in platelets (2.6-4.8 microm). Upon thrombin/convulxin stimulation caspase inhibitors prevented microparticle (MP) formation, while a calpain inhibitor stimulated MP formation. It was also shown that stimulated platelets are heterogeneous not only in their ability to activate alpha IIb beta 3 integrin complex and expose PS on their surface, but also in the distribution of activation markers, which strongly depends on platelet/particle size and that platelets/particles of different sizes provide different responses to the same stimulus.
已证明,由凝血酶/convulxin联合刺激的血小板会形成两到三个群体,其特征是具有不同的磷脂酰丝氨酸(PS)表面表达和整合素αIIbβ3活性。为了确定这些标志物如何分布在血小板/颗粒表面,我们通过流式细胞术分析研究了膜联蛋白V和PAC-1与不同大小的血小板/颗粒的结合情况,并评估了钙蛋白酶和半胱天冬酶抑制剂对凝血酶/convulxin激活的血小板的影响。根据标准尺寸微珠,将分析的血小板/颗粒按大小分为七个群体,直径从0.37到4.8微米。在直径为1.2至4.8微米的血小板/颗粒中,每平方微米的PAC-1结合量几乎相等,而在较小尺寸的颗粒(0.37 - 0.7微米)上则显著较低。每平方微米的PS表面暴露量在直径为0.37 - 1.2微米的颗粒中较高,而在血小板(2.6 - 4.8微米)中非常低。在凝血酶/convulxin刺激后,半胱天冬酶抑制剂可阻止微粒(MP)形成,而钙蛋白酶抑制剂则刺激MP形成。还表明,受刺激的血小板不仅在激活αIIbβ3整合素复合物和在其表面暴露PS的能力方面存在异质性,而且在激活标志物的分布方面也存在异质性,这在很大程度上取决于血小板/颗粒的大小,并且不同大小的血小板/颗粒对相同刺激的反应不同。